Friday, 07 June 2024 Newsmax Health An extended course of the antiviral drug Paxlovid won’t ease a person’s long COVID symptoms, a new study finds. People who took Paxlovid for…[...]
SARS-CoV-2 keeps changing. What does this mean for the treatment of COVID-19? By EKATERINA PESHEVA January 3, 2023 Research Harvard As the world enters year four of the COVID-19 pandemic, scientists have…[...]
However, the drug remains one of the most effective ways of preventing serious illness and death Published 11/14/23, Sarah Braner The Messenger Viral rebound after taking Paxlovid may be more common than…[...]
With so many treatment candidates, researchers work to gain more clarity by Shi En Kim September 11, 2023 | A version of this story appeared in Volume 101, Issue 30 Hannah Davis…[...]
Story by Nacha Cattan Sept 21, 2023 Bloomberg A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data…[...]
Alex Tan August 23, 2023 Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the…[...]
Covid patients who use Paxlovid are twice as likely to suffer an infection rebound In a study, a third of patients who used the drug had their Covid return It…[...]
Authors: Jim Hoft Published October 13, 2022 A new study warned that Pfizer’s Paxlovid COVID-19 pill can have harmful interactions with common medications used to treat cardiovascular disease, as what…[...]
Virus remaining in some people’s bodies for a long time may be causing longer-term complications, recent research suggests Authors: Sumathi Reddy Sept. 8, 2022 The Wall Street Journal The virus…[...]
Authors: Bart Jones August 27, 2022 Newsday Some medical experts on Long Island are disputing a new study that said Paxlovid did not help relieve COVID-19 symptoms in people under 65.…[...]